BPA for tiglutik
Active Awarded Last action
- Contract number
- 36E79722A0009
- Awardee
-
EDW Pharma, Inc. UEI GMPSJ4GJKW66
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 98% complete
- IDV ceiling
- $848,847.60
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Blanket Purchase Agreement, awarded on December 1, 2021, by the National Acquisition Center (a civilian federal agency) to EDW Pharma, Inc., establishes a single-award indefinite delivery vehicle for the procurement of Tiglutik with a ceiling value of $848,847.60. The contract operates under the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is scheduled for ultimate completion on November 30, 2026. No set-aside provisions were applied to this award, indicating competition was conducted in the open market. Tiglutik is a prescription pharmaceutical product indicated for amyotrophic lateral sclerosis (ALS) treatment, and this BPA structure allows the government to issue delivery orders against the established pricing and terms throughout the contract period.
The contract incorporates 2026 public law pricing updates, which establishes a mechanism for pricing adjustments in accordance with applicable federal legislation during the agreement's performance period. As a Blanket Purchase Agreement, this vehicle provides the government with flexibility to issue task orders or delivery orders for Tiglutik supplies as needed, rather than committing to fixed quantities upfront. The arrangement with EDW Pharma, Inc. streamlines the procurement process for this pharmaceutical product while maintaining cost controls through the established ceiling value and GSA schedule pricing framework, ensuring the government obtains competitive pharmaceutical pricing for this specialty medication.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 11
Quick answers
Who was awarded contract 36E79722A0009?
36E79722A0009 was awarded to EDW Pharma, Inc. by National Acquisition Center (Headquarters) on December 1, 2021.
How much is contract 36E79722A0009 worth?
36E79722A0009's own ceiling is $848,848.
Who can order from contract 36E79722A0009?
36E79722A0009 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79722A0009 under another contract?
Yes. 36E79722A0009 is a blanket purchase agreement under 36F79719D0241, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79722A0009 competed?
The extent of competition for 36E79722A0009 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV